To illuminate the evolving landscape of resistance, we developed MeRLin, a lineage tracing platform that integrates cellular barcoding, single-cell transcriptomics, and RNA-FISH to simultaneously track clonal evolution, transcriptional plasticity, and spatial organization in melanoma under BRAF/MEK inhibition6. The gene discussed is MAP2K7; the disease is melanoma.